1. AMPK Inhibition Enhances the Neurotoxicity of Cu(II) in SH-SY5Y Cells
   Ai-ping Lan et al, 2016, Neurotoxicity Research CrossRef
2. Integrated multi‑omics data analysis identifying novel drug sensitivity‑associated molecular targets of hepatocellular carcinoma cells
   Gokhan Yildiz, 2018, Oncology Letters CrossRef
3. 4-Acetylantrocamol LT3, a New Ubiquinone from Antrodia cinnamomea, Inhibits Hepatocellular Carcinoma HepG2 Cell Growth by Targeting YAP/TAZ, mTOR, and WNT/β-Catenin Signaling
   Yen-Lin Chen et al, 2020, The American Journal of Chinese Medicine CrossRef
4. The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
   Xue Jiang et al, 2019, Cancers CrossRef
5. MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A
   Wenyue Zhao et al, 2022, Annals of Hepatology CrossRef
6. Progression of conventional hepatic cell culture models to bioengineered HepG2 cells for evaluation of herbal bioactivities
   Pardeep Kaur et al, 2018, Biotechnology Letters CrossRef